Given its expression on the surface of cells in several cancers, it has been exploited for nanoparticle delivery in conjunction with fractionated radiation therapy employing MUC1-conjugated nanoparticles in breast and lung cancer [117]. The gene discussed is MUC1; the disease is lung carcinoma.